Profitability Metrics

Gross Margin
50.45%
Operating Margin
0.00%
Net Margin
-3.97%

Efficiency Metrics

Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
9.16%
Income Tax Rate
106,200,000.0%
EPS
-0.1200000000

Balance Sheet Analysis

Current Ratio
5.08
Cash Ratio
0.40
Working Capital
$2.65B
Debt to Equity
2.14
Debt to Assets
65.24%
Equity Ratio
30.43%

Cash Flow Analysis

Operating Cash Flow Ratio
35.10%
Free Cash Flow Ratio
33.30%
CapEx to Revenue
1.80%
Dividends Paid
$103.95M
Stock Buybacks
$2.89M
Total Shareholder Returns
$106.84M
Cash Position Change
-9.21%

Key Takeaways (2023 FY)

  • Increased dividend payments by 4.79%

Detailed Growth Metrics

Core Performance

Revenue
9.36%
Net Income
-133.96%
EPS
-134.29%
Operating Income
-100.00%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
8.33%
Operating Cash Flow
9.86%
Free Cash Flow
13.45%

Balance Sheet Health

Assets
-11.62%
Debt
-14.15%
Book Value per Share
-7.78%
Inventory
0.00%

Shareholder Returns

Dividends per Share
4.79%
Shares Outstanding
-0.19%

Long Term Trends

3Y Revenue/Share
-6.52%
5Y Revenue/Share
-21.33%
3Y Dividend/Share
103.39%
5Y Dividend/Share
-46.72%